Ignite Creation Date:
2025-12-25 @ 1:22 AM
Ignite Modification Date:
2026-02-05 @ 6:04 PM
Study NCT ID:
NCT07223593
Status:
RECRUITING
Last Update Posted:
2025-12-24
First Post:
2025-10-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Sponsor:
Eli Lilly and Company
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Peripheral Arterial Disease | View |
Keywords: